ShipelinVATrusovNVApryatinSAShumakovaAATimoninANRigerNAet al
No adverse developmental effects were observed when alogliptin was administered to pregnant rats and rabbits during organogenesis at exposures 180 and 149 times the 25 mg clinical dose, respectively, based on plasma drug exposure (AUC) [see Data]
However, no formal cost-effectiveness analysis was performed in the present review, and we did not identify a robust economic evaluation specifically addressing women with PCOS undergoing fertility treatment or ART pretreatment
"There are some notable challenges and outstanding questions with the currently planned structure," the company's chief of government programs said on an earnings call this morning
Lets dive into the evidence and see what makes this approach effective
That immediately, and quite rightly, raises eyebrows